ArticleOphthalmology science2026
External Validation and Comparison of Automated Retinal Image Quality Grading Methods in the Canadian Longitudinal Study on Aging.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To externally validate and compare automated retinal image quality grading using a multiple color-space fusion network (MCF-Net) and a vessel-based fractal dimension (FD) score in the Canadian Longitudinal Study on Aging (CLSA). Design: Cross-sectional external validation study. Participants: There are 7263 baseline color fundus photographs from CLSA participants. Methods: Images were resized and normalized and then converted to red, green, and blue/hue, saturation, and value/Lab for MCF-Net; FD was computed from the segmented vasculature. Two of 3 expert graders assigned 3-tier reference labels (good, fair, poor/ungradable). To enable fair external comparison between probabilistic (MCF-Net) and continuous (FD) outputs, predictions were mapped onto a common ordinal scale aligned with expert grading, and operating cut points were selected within the CLSA data set to address class imbalance by maximizing macro-averaged F1. Performance was also evaluated in binary tasks (good vs. non-good and poor/ungradable vs. non-poor/ungradable). Main Outcome Measures: Macro-averaged F1 for 3-class grading; quadratic-weighted kappa; accuracy; and F1 for poor/ungradable detection. Results: Multiple color-space fusion network outperformed FD on 3-class grading (accuracy, 85.0% vs. 83.9%; macro-F1, 0.739 vs. 0.673; quadratic-weighted κ, 0.843 vs. 0.792). Gains were largest for poor/ungradable detection (F1, 0.808 vs. 0.625). Agreement with expert ranking was higher for MCF-Net. Both methods performed best for good and poor/ungradable images; fair remained the most challenging category. Conclusions: In this population-based external validation study, MCF-Net showed modest overall gains compared with FD, but its principal advantage was improved detection of poor/ungradable images. This distinction is clinically relevant because missed poor/ungradable images may create false reassurance in screening or epidemiologic workflows. By introducing a unified evaluation framework that enables fair comparison between probabilistic and continuous outputs, this study addresses a practical barrier to validating automated image-quality tools in clinical screening and population-based cohort studies. The observed error profile of MCF-Net-marked by improved detection of poor/ungradable images and conservative reclassification of borderline cases-aligns with the priorities of screening and epidemiologic workflows, where false reassurance poses greater risk than additional image review or retakes. These findings support further development and prospective evaluation of automated retinal image quality assessment before potential integration into large-scale workflows. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.